Literature DB >> 33343252

Performance in Practice: Practice Assessment Tool for the Care of Patients With Schizophrenia.

Laura J Fochtmann1, Jennifer Medicus1, Seung-Hee Hong1.   

Abstract

Schizophrenia is associated with significant health, social, occupational, and economic burdens, including increased mortality. Despite extensive and robust research on the treatment of individuals with schizophrenia, many individuals with the illness do not currently receive evidence-based pharmacological and nonpharmacological treatments. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition, aims to enhance knowledge and increase the appropriate use of interventions for schizophrenia, thereby improving the quality of care and treatment outcomes. To this end, this evidence-based Performance in Practice tool can facilitate the implementation of a systematic approach to practice improvement for the care of individuals with schizophrenia. This practice assessment activity can also be used in partial fulfillment of Continuing Medical Education and Maintenance of Certification, part IV, requirements, which can also satisfy requirements for the Centers for Medicare & Medicaid Services Merit-based Incentive Payment System program.
Copyright © by the American Psychiatric Association.

Entities:  

Keywords:  Schizophrenia

Year:  2020        PMID: 33343252      PMCID: PMC7725154          DOI: 10.1176/appi.focus.20200034

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN: 1541-4094


  152 in total

Review 1.  The Current State of Behavioral Health Quality Measures: Where Are the Gaps?

Authors:  Milesh M Patel; Jonathan D Brown; Sarah Croake; Rita Lewis; Junqing Liu; Lisa Patton; D E B Potter; Sarah Hudson Scholle
Journal:  Psychiatr Serv       Date:  2015-06-15       Impact factor: 3.084

2.  Acute risk of suicide and suicide attempts associated with recent diagnosis of mental disorders: a population-based, propensity score-matched analysis.

Authors:  Jason R Randall; Randy Walld; Greg Finlayson; Jitender Sareen; Patricia J Martens; James M Bolton
Journal:  Can J Psychiatry       Date:  2014-10       Impact factor: 4.356

3.  Quality Measures For Mental Health And Substance Use: Gaps, Opportunities, And Challenges.

Authors:  Harold Alan Pincus; Sarah Hudson Scholle; Brigitta Spaeth-Rublee; Kimberly A Hepner; Jonathan Brown
Journal:  Health Aff (Millwood)       Date:  2016-06-01       Impact factor: 6.301

4.  Cigarette Smoking by Patients With Serious Mental Illness, 1999-2016: An Increasing Disparity.

Authors:  Faith Dickerson; Jennifer Schroeder; Emily Katsafanas; Sunil Khushalani; Andrea E Origoni; Christina Savage; Lucy Schweinfurth; Catherine R Stallings; Kevin Sweeney; Robert H Yolken
Journal:  Psychiatr Serv       Date:  2017-09-15       Impact factor: 3.084

5.  Twelve-Month Health Care Use and Mortality in Commercially Insured Young People With Incident Psychosis in the United States.

Authors:  Michael Schoenbaum; Jason M Sutherland; Andre Chappel; Susan Azrin; Amy B Goldstein; Agnes Rupp; Robert K Heinssen
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

6.  Translating cognitive behavioral interventions from bench to bedside: The feasibility and acceptability of cognitive remediation in research as compared to clinical settings.

Authors:  Alice Medalia; Matthew D Erlich; Charlotte Soumet-Leman; Alice M Saperstein
Journal:  Schizophr Res       Date:  2017-07-30       Impact factor: 4.939

7.  Treatment engagement of individuals experiencing mental illness: review and update.

Authors:  Lisa B Dixon; Yael Holoshitz; Ilana Nossel
Journal:  World Psychiatry       Date:  2016-02       Impact factor: 49.548

Review 8.  Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies.

Authors:  Filippo Varese; Feikje Smeets; Marjan Drukker; Ritsaert Lieverse; Tineke Lataster; Wolfgang Viechtbauer; John Read; Jim van Os; Richard P Bentall
Journal:  Schizophr Bull       Date:  2012-03-29       Impact factor: 9.306

9.  The relationship between suicide and violence in schizophrenia: analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) dataset.

Authors:  Katrina Witt; Keith Hawton; Seena Fazel
Journal:  Schizophr Res       Date:  2014-02-26       Impact factor: 4.939

Review 10.  Prevalence and Medical Costs of Chronic Diseases Among Adult Medicaid Beneficiaries.

Authors:  John M Chapel; Matthew D Ritchey; Donglan Zhang; Guijing Wang
Journal:  Am J Prev Med       Date:  2017-12       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.